Emerging Genetic Therapies in Epilepsy
Seminars in Neurology · 01.04.2025 · 45 (02) · 298-302
DOI: 10.1055/a-2544-1530 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Seminars in Neurology, erschienen am 01.04.2025. Verfasst von Joseph Sullivan und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, University of California San Francisco, San Francisco, California. Hauptthemen laut MEDLINE: Genetic Therapy, Epilepsy, Epilepsies, Myoclonic. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 28 Literaturangaben.
Abstract (Originalsprache)
Advances in next-generation sequencing have allowed for genetic characterization of many epilepsies that previously had no known cause. Although having a precise diagnosis has been very helpful for management, counseling, and prognosis, until recently true precision medicine approaches that could have disease-modifying effects have been lacking. This review will highlight how preclinical animal models of Dravet syndrome have allowed some novel gene therapy approaches to be studied and further developed such that they are now entering into the clinics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Neurology, University of California San Francisco, San Francisco, California.
- Epilepsy Division, Dravet Syndrome Foundation, Cherry Hill, New Jersey.
ORCID-Profile: Joseph Sullivan, Veronica Hood
Zitieren
APA
Sullivan, J., & Hood, V. (2025). Emerging Genetic Therapies in Epilepsy. Seminars in Neurology, 45(02), 298-302. https://doi.org/10.1055/a-2544-1530
Vancouver
Sullivan J, Hood V. Emerging Genetic Therapies in Epilepsy. Seminars in Neurology. 2025;45(02):298-302. doi:10.1055/a-2544-1530
BibTeX
@article{Sullivan2025,
author = {Sullivan, Joseph and Hood, Veronica},
title = {Emerging Genetic Therapies in Epilepsy},
journal = {Seminars in Neurology},
year = {2025},
volume = {45},
number = {02},
pages = {298--302},
doi = {10.1055/a-2544-1530}
}
EUVIMED